default author photo

Yu-Shang Yang

Sichuan University

SCHOLARLY PAPERS

1

DOWNLOADS

69

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Neoadjuvant Chemotherapy Combined with Camrelizumab for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study

Number of pages: 23 Posted: 21 Feb 2024
Sichuan University, Sichuan University, Sichuan University, Sichuan University - Department of Thoracic Surgery, Sichuan University, Sichuan University, Sichuan University, Sichuan University, Sichuan University, Sichuan University, Sichuan University, Sichuan University, Sichuan University - Department of Biotherapy, Sichuan University - Collaborative Innovation Center for Biotherapy and Sichuan University - Department of Biotherapy
Downloads 69 (883,195)

Abstract:

Loading...

neoadjuvant immunotherapy, camrelizumab, esophageal squamous cell carcinoma, clinical efficacy, immune response